Transparency Market Research Report Added “Hemoglobin A1c Testing Devices Market” to its database.
Hemoglobin A1c Testing Devices Market: Descirption
Determining the levels of glycated hemoglobin gives assurance to healthcare practitioners about decision making on the treatment to be prescribed to diabetic patients. Such tests are primarily used for diagnosis and monitoring of hemoglobin A1c levels. Hemoglobin A1c test provides the average amount of patient’s glucose levels in last 2 to 3 months, therefore, it is preferred over other conventionally used blood glucose tests. Due to this reason, medical practitioners are increasingly recommending hemoglobin A1c testing devices over glucose testing devices to diabetic patients which has lead to increased use of hemoglobin A1c testing devices.
This study covers the market analysis for various technologies and end-uses of hemoglobin A1c (HbA1c) testing devices. The stakeholders for this report include manufacturers of hemoglobin A1C testing analyzers, research organizations involved in developing new and innovative technologies for hemoglobin A1c testing devices and the new players who wish to enter this market. The report consists of executive summary, which provides the market snapshot containing the information of segments of hemoglobin A1c testing devices market. This section also includes the comparative analysis of hemoglobin A1c market based on different geographical regions.
Browse Market Research Report:
Hemoglobin A1c Testing Devices Market: Segments
Testing the levels of glycated hemoglobin provides an assurance to the healthcare practitioner about the patient’s blood glucose level. This test can be used for diagnosis and monitoring of hemoglobin A1c levels in diabetic patients. Since A1C test reflects the average amount of glucose for the past 2 to 3 months, it is opined to be more reliable than conventional blood glucose test. Physicians are increasingly prescribing HbA1c test to their patients which will lead to an increase in the test volume. Moreover, rising diabetes incidence rate is a major driver for the HbA1c testing market. With growing awareness about prevention and management of diabetes, the demand for HbA1c testing devices will rise rapidly especially in the Asia-Pacific, Latin America, MiddleEast and African regions.
Moreover, advent of these devices for the diagnosis of diabetes will further bolster the demand for these devices in future. For instance, approval for the COBAS INTEGRA 800 Tina-quant HbA1cDx assay, in 2013and Abbott’s ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test approved in 2014 for the diagnosis of diabetes were the major steps in the hemoglobin A1c testing industry. With this diagnostic tools, physicians can combat the rising incidence of diabetes with timely and appropriate actions in identifying and managing diabetes.
Based on the end-use, the global hemoglobin A1c testing devices market is categorized into two segments namely laboratory testing and point-of-care (POC) testing devices. Laboratory testing devices held the majority share of the market in 2012, while the global market for point-of-care testing devices is expected to grow at a faster paceduring the forecast period.
Fill the form for an exclusive sample of this report:
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
Browse market research blog: https://tmrresearch.blogspot.com/